vimarsana.com

Latest Breaking News On - Liver cancer association - Page 1 : vimarsana.com

Lung Responses to Atezolizumab/Bevacizumab Linked With OS in HCC and Pulmonary Metastasis

Second-Line Regorafenib Demonstrates Safety in Advanced HCC, Irrespective of Prior Treatment

Cabozantinib Is Safe and Tolerable in Sorafenib-Intolerant HCC

The phase 2 ACTION trial, which evaluated the safety of second-line cabozantinib in patients with hepatocellular carcinoma who were intolerant to first-line sorafenib or who received agents other than sorafenib in the first line, did not meet its safety futility criteria, allowing the trial to continue.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.